Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
A Deep Learning Approach Accurately Estimates RNFL Thickness in OCT Scans Where Instrument-Native Segmentation Fails
Author Affiliations & Notes
  • Benton Gabriel Chuter
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Justin Huynh
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Mark Christopher
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Ruben Cesar Gonzalez
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Evan Walker
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Sally Liu Baxter
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
    Department of Biomedical Informatics, University of California San Diego Health System, San Diego, California, United States
  • Akram Belghith
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Christopher Bowd
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Michael Henry Goldbaum
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Jeffrey M Liebmann
    Department of Ophthalmology, Harkness Eye Insititute, Bernard and Shirlee Brown Glaucoma Research Laboratory, New York, New York, United States
  • Massimo Antonio Fazio
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Christopher A Girkin
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Robert Weinreb
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Linda M Zangwill
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Benton Chuter None; Justin Huynh None; Mark Christopher AISight Health, Code P (Patent); Ruben Gonzalez None; Evan Walker None; Sally Baxter voxelcloud.io, Code C (Consultant/Contractor), Optomed, Topcon, Code F (Financial Support), iVista Medical Education, Code R (Recipient); Akram Belghith None; Christopher Bowd None; Michael Goldbaum None; Jeffrey Liebmann Allergan, Genentech, Thea, Bausch & Lomb, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness , Code F (Financial Support); Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Topcon and Wolfram Research, Code F (Financial Support); Christopher Girkin National Eye Institute,Heidelberg Engineering and Topcon, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Iantrek, Implandata, Nicox, Topcon Medical, Code C (Consultant/Contractor), Bausch & Lomb, Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent); Linda Zangwill Abbvie Inc. Topcon , Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc. , Code F (Financial Support), Zeiss Meditec AISight Health, Code P (Patent)
  • Footnotes
    Support   EY11008, EY19869, EY14267, EY027510, EY026574, EY029058, P30EY022589, and participant retention incentive grants in the form of glaucoma medication at no cost from Novartis/Alcon Laboratories Inc, Allergan, Akorn, and Pfizer Inc. Unrestricted grant from Research to Prevent Blindness, New York, New York. UCSD MedGap Program.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2385. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benton Gabriel Chuter, Justin Huynh, Mark Christopher, Ruben Cesar Gonzalez, Evan Walker, Sally Liu Baxter, Akram Belghith, Christopher Bowd, Michael Henry Goldbaum, Jeffrey M Liebmann, Massimo Antonio Fazio, Christopher A Girkin, Robert Weinreb, Linda M Zangwill; A Deep Learning Approach Accurately Estimates RNFL Thickness in OCT Scans Where Instrument-Native Segmentation Fails. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2385.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal nerve fiber layer (RNFL) analysis from optical coherence tomography (OCT) is crucial to the diagnosis and treatment of glaucoma. Established models use proprietary algorithms for retinal layer segmentation, which are susceptible to error. The purpose of this study is to evaluate the performance of 3 segmentation-free deep learning (DL) models, trained to estimate RNFL thickness from unsegmented OCT imaging in both cases where traditional segmentation was correct and incorrect.

Methods : 25,371 OCT Spectralis optic nerve head (ONH) circle scans from the Diagnostic Innovations in Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES) datasets from 981 patients (1567 eyes) were collected. This dataset was then divided into 3 groups by patient: a training (20,528 images) set, a test set composed of OCT images that required no manual segmentation correction (n=1936), and a test set that required manual segmentation (n=2907). These circle scans were each associated with 768 RNFL thickness values, used as ground truth. Three DL architectures, ResNet50, Densenet121, and EfficientNetB0, all trained on the common training set were used to predict RNFL thickness from unsegmented OCT circle scans. They were applied to both testing sets, with OCT images where segmentation had either succeeded (n=1936 scans) or failed (n=2907 scans). Performance was defined as mean absolute error (MAE) and root mean squared error (RMSE) compared to the instrument software RNFL thickness measurement.

Results : Performance did not significantly differ between the two test sets (MAEs 20.24, 21.39, 19.97 vs 19.11, 19.44, 19.8; RMSEs 26.77, 29.09, 26.56 vs 25.30, 26.55, 25.27). Stratification by race, sex, age, and glaucoma status did not demonstrate significant differences in performance within these testing sets.

Conclusions : A DL model can accurately determine RNFL thickness from OCT images without explicit segmentation across patient demographic and diagnostic groups, even in scans where existing segmentation approaches failed. This segmentation-free method enables accurate RNFL thickness estimation in the presence of segmentation errors, potentially reducing the impact of such errors and the need for manual correction.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1: MAEs and RMSEs for ResNet50, DenseNet121, and EfficientNetB0 for the test sets.

Figure 1: MAEs and RMSEs for ResNet50, DenseNet121, and EfficientNetB0 for the test sets.

 

Table 1: Clinical and demographic characteristics of the data sets.

Table 1: Clinical and demographic characteristics of the data sets.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×